15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Tyra Biosciences Inc, 11 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $42.00 to $59.00, a moderate spread. The average target of $50.80 sits 90% above the current $26.76. The rating mix has stayed broadly stable, with Buy-side ratings easing from 12 to 11 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.71 next quarter toward $-2.96 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Strong Buy
Strong Buy00%
Buy1192%
Hold18%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to Tyra Biosciences Inc.
As of Sep, 11 of 12 firms rate TYRA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TYRA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.71
Range $-0.78 – $-0.60 · 14 analysts · +24% YoY
Next period, 14 analysts expect Tyra Biosciences Inc to earn $-0.71 a share (range $-0.78 – $-0.60), versus $-0.57 a year earlier. Full-year consensus is $-2.67, growing to $-2.96 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 14 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Tyra Biosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TYRA.
#1
Mitchell Kapoor
HC Wainwright & Co. · Rank #193
Buy
$45.00+68.2% to target
Overall win rate
34%
+ Follow
#2
Li Watsek
Cantor Fitzgerald · Rank #275
Buy
No targeton TYRA
Overall win rate
36%
+ Follow
#3
Robert Driscoll
Wedbush · Rank #375
Buy
$53.00+98.1% to target
Overall win rate
30%
+ Follow
#4
John Newman
Canaccord Genuity · Rank #409
Buy
$50.00+86.8% to target
Overall win rate
30%
+ Follow
#5
Matthew Biegler
Oppenheimer
Buy
$50.00+86.8% to target
Coverage
—
+ Follow
TYRA stock forecast FAQ
What is TYRA's average 12-month price target?+
The 10 analysts with a live target average $50.80 for Tyra Biosciences Inc over the next 12 months, ranging from a $59.00 high to a $42.00 low.
Is TYRA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 12 analyst ratings, 11 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TYRA?+
The Street-high target is $59.00 (Barclays), and the Street-low is $42.00 (B of A Securities). The average of all 10 active targets is $50.80.
How many Wall Street analysts cover TYRA?+
12 analysts have an active rating on Tyra Biosciences Inc, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering TYRA?+
Among analysts who currently cover TYRA, Mitchell Kapoor of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #193). Their current call is Buy with a $45.00 target.
What is Tyra Biosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.71 per share (range $-0.78 – $-0.60) across 14 analysts. Full-year EPS is projected at $-2.67, rising to $-2.96 the following year.
How much revenue is Tyra Biosciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading TYRA lately?+
As of Sep, 11 of 12 firms rate TYRA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TYRA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Jones Trading
